The first stop for professional medicines advice

Medicines planning

40 results

Applied filters

Good governance when implementing tocilizumab biosimilar

5 March 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.

Good governance when implementing ranibizumab biosimilar

29 June 2022Governance should consider processes for approval; procurement and supply; prescribing and administration; monitoring; and pharmacovigilance

Good governance when implementing natalizumab biosimilar

6 February 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring and pharmacovigilance.

Good governance when implementing eculizumab biosimilar

6 March 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring, and pharmacovigilance.

Costing Clinical Trials of ATIMPs using the NIHR iCT - Advice for Pharmacy Sites

12 July 2022Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.

Biosimilars

Regularly updated material to support the introduction of eculizumab, golimumab, natalizumab, ranibizumab, tocilizumab and ustekinumab biosimilars.

Biosimilar and key generic medicines July 2025 update

28 May 2025An update supporting system implementation of biosimilar and key generic medicines.

Biosimilar and key generic medicines - April 2025 update

9 April 2025An update supporting implementation of biosimilar and key generic medicines for aflibercept, golimumab, nilotinib and ferric carboxymaltose.
Registration required

Annual medicines planning publication, Prescribing Outlook

28 October 2022Our annual output to support managed entry and budget planning for new medicines, new indications and patent expiries in the NHS.

Annual medicines planning

Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.